Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
Cancer Biotherapy & Radiopharmaceuticals|November 6, 2007
Safety and efficacy of yttrium-90 ibritumomab tiuxetan in older patients with non-Hodgkin's lymphomaChristos Emmanouilides, Thomas E Witzig, Gregory A Wiseman, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2009
Impact of rituximab treatment on (90)Y-ibritumomab dosimetry for patients with non-Hodgkin lymphomaSui Shen, Andres Forero, Ruby F Meredith, et al.European Journal of Radiology|September 1, 2009
18F-FDG PET and PET/CT in Burkitt's lymphomaDimitrios Karantanis, Jolanta M Durski, Val J Lowe, et al.Leukemia & Lymphoma|May 13, 2006
Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphomaChristos Emmanouilides, Thomas E Witzig, Leo I Gordon, et al.Leukemia & Lymphoma|September 13, 2006
Marrow irradiation with high-dose 153Samarium-EDTMP followed by chemotherapy and hematopoietic stem cell infusion for acute myelogenous leukemiaVilmarie Rodriguez, Peter M Anderson, Mark R Litzow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastasesPeter M Anderson, Gregory A Wiseman, Angela Dispenzieri, et al.Clinical Lymphoma & Myeloma|May 27, 2008
The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphomaDimitrios Karantanis, Rathan M Subramaniam, Patrick J Peller, et al.Cancer|March 24, 2007
Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetanThomas E Witzig, Arturo Molina, Leo I Gordon, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2002
Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibodyHenry N Wagner, Gregory A Wiseman, Carol S Marcus, et al.Nature Reviews. Gastroenterology & Hepatology|November 3, 2009
Liver transplantation after radioembolization in a patient with unresectable HCCLaura E Moreno Luna, Paul Y Kwo, Lewis R Roberts, et al.Pageof 6